Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin (Q74371244)
Jump to navigation
Jump to search
scientific article published on 01 February 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin |
scientific article published on 01 February 1998 |
Statements
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin (English)
G Todeschini
C Tecchio
V Meneghini
G Pizzolo
D Veneri
R Zanotti
M M Ricetti
P Solero
F April
1 February 1998